Thermo Fisher Scientific acknowledges the value of supporting independent research projects in order to promote
excellence in molecular diagnostics.
The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects, on molecular testing in oncology and reproductive health, with the goal to increase high quality molecular profiling for patients and to improve clinical outcomes in the future.
Proposal reviews are conducted by independent and internationally recognized experts together with Thermo Fisher Scientific medical and scientific leadership. Funding is considered based on scientific merit and alignment with strategic areas of focus.
The application process is managed by the Oncomine Clinical Research Grant Office part of the Medical Affairs team of the Clinical Sequencing Division at Thermo Fisher Scientific. For detailed information about how to apply, including documentation requirements, review process, and decision notification, refer to the document Guidelines for Applicants.
Grant applications should be submitted electronically (English only) using the specific Proposal Form. Proposals should outline the planned activities to be performed within a maximum of 12 months. A budget is required for every grant request and should detail the proposed use of requested funds. The maximum budget request for each project is set at $200,000.
GRANT SUBMISSION DATES:
Submissions are open from February 22 to March 29, 2021.
TOPICS OF CALL:
Liquid Biopsy in Oncology
For any questions about the Oncomine Clinical Research Grant Program, please email firstname.lastname@example.org